Featured Research

from universities, journals, and other organizations

Dormant Viruses Re-Emerge in Patients with Lingering Sepsis, Signaling Immune Suppression

Date:
June 12, 2014
Source:
Washington University in St. Louis
Summary:
A provocative study links prolonged episodes of sepsis — a life-threatening infection and leading cause of death in hospitals — to the reactivation of otherwise dormant viruses in the body. In healthy people, such latent viruses are kept in check by the immune system. But a new study provides strong evidence that when sepsis lingers for more than a few days, which is common, viruses re-emerge and enter the bloodstream, signaling that the immune system has become suppressed.

The data show the rate of viral conversion for septic patients whose blood or plasma initially tested negative for virus and who subsequently became positive during the course of their sepsis. The time is in days after patients met the criteria for a diagnosis of sepsis. Of the septic patients, overall 24 percent were positive for CMV, 53 percent for EBV, 14 percent for HSV, 10 percent for HHV-6 and 78 percent for TTV. Abbreviations: Cytomegalovirus, CMV; Epstein-Barr virus, EBV; HSV, herpes simplex viruses 1 and 2; HHV-6, human herpes virus 6; Torque teno virus, TTV.
Credit: Citation: Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, et al. (2014) Reactivation of Multiple Viruses in Patients with Sepsis. PLoS ONE 9(6): e98819. doi:10.1371/journal.pone.0098819

A provocative study links prolonged episodes of sepsis -- a life-threatening infection and leading cause of death in hospitals -- to the reactivation of otherwise dormant viruses in the body.

Related Articles


In healthy people, such latent viruses are kept in check by the immune system. But a study by a team at Washington University School of Medicine in St. Louis provides strong evidence that when sepsis lingers for more than a few days, which is common, viruses re-emerge and enter the bloodstream, signaling that the immune system has become suppressed. This state of immune suppression may leave patients unable to fight off secondary infections, such as pneumonia associated with being on a ventilator.

The research, published June 11 in PLOS One, suggests that drugs that "rev up" the immune system could be incorporated into the treatment of prolonged sepsis.

"A controversy has existed over whether patients with sepsis progress to a state of immune suppression," said co-senior author Gregory Storch, MD, a virologist and chief of the Division of Pediatric Infectious Diseases. "The finding that critically ill patients with sepsis have a number of different viruses circulating in the bloodstream is compelling evidence they are immune-suppressed and dramatically could alter therapy for sepsis."

Surprisingly, the researchers detected levels of viruses in sepsis patients that were on par with those seen in patients who have had organ transplants and are taking immune-suppression drugs to prevent rejection.

"This is an indicator of the degree of immune suppression in septic patients, and it tells us they are highly immune-suppressed," explained senior author Richard S. Hotchkiss, MD, professor of anesthesiology.

More than 200,000 patients in the United States die annually of sepsis. The condition develops when the body mounts a massive immune response to infection, triggering excessive inflammation that can lead quickly to organ failure. While some patients die soon after the condition develops, most sepsis deaths occur four or more days after onset.

"We've gotten much better at getting sepsis patients through the initial phase," said Hotchkiss, who also is a professor of medicine and of surgery. "But too many patients die several weeks or months after sepsis sets in, primarily of secondary infections."

Earlier research at Washington University and other institutions has hinted that lingering sepsis may be linked to immune suppression. But a lack of compelling evidence has kept the debate going.

For the current study, first authors Andrew Walton and Jared Muenzer, MD, used polymerase chain reaction (PCR) testing to detect a range of viruses in blood and urine samples from 560 critically ill patients with sepsis, who were treated in the surgical and medical intensive care units at Barnes-Jewish Hospital. As a comparison, they performed the same test on 161 critically ill patients in the hospital who did not have sepsis and 164 healthy patients who were having outpatient surgery.

"We were looking for viruses that people are commonly exposed to early in life and that persist in the body in a latent form that doesn't cause sickness," said Storch, the Ruth L. Siteman Professor of Pediatrics. "No one had really looked at this in a comprehensive fashion before. These viruses have the potential to reactivate if the immune system is suppressed."

Patients with lingering sepsis had markedly higher levels of viruses detectable in the blood, compared with the healthy controls and critically ill patients without sepsis. Among the sepsis patients, for example, the researchers found that 53 percent had Epstein-Barr virus, 24 percent had cytomegalovirus, 14 percent had herpes-simplex virus, and 10 percent had human herpes simplex virus-7.

These viruses generally don't lead to significant illness in people who are healthy but can cause problems in patients who are immune-suppressed.

The researchers noted that 43 percent of patients with sepsis had two or more viruses detected in their blood or urine during their hospital stays. However, this finding may underestimate the frequency of viral infections because some of these patients were not tested for all viruses. In a subgroup of 209 sepsis patients tested for all viruses, 54 percent were positive for two or more.

Additionally, the researchers found that septic patients with higher levels of viruses detected in their blood were more likely than critically ill patients without sepsis to have more severe illnesses, secondary fungal and bacterial infections, and longer stays in the intensive care unit.

Also, septic patients with evidence of cytomegalovirus in plasma, a component of blood, had significantly higher 90-day death rates than septic patients who tested negative for the virus, although it is not clear whether the cytomegalovirus contributed to the additional deaths.

"We stumbled onto more viruses than we expected, and we don't know yet whether some of these viruses are causing problems in their own right," Storch said. "We think this paper will stimulate others to carry out further investigations of the role of latent viruses in sepsis."

A further direction for researchers is to determine whether PCR testing for a panel of latent viruses could be used as a readout of the state of a person's immunity. If this is the case, doctors could perform PCR testing in patients with cancer, autoimmune diseases and infections and use results to guide treatments.

The findings also open the door to new ways of treating sepsis. Over the years, a number of treatments have been evaluated to treat sepsis, but none has worked well. The new research indicates that, in addition to using powerful antibiotics to fight off infections in patients with sepsis, immunotherapy drugs that boost the immune system may be an effective therapy. The Washington University team is planning several clinical trials of such drugs in sepsis patients in the near future.

The research was funded by the National Institutes of Health (NIH), grants GM 441181, GM55194, GM 09839, Al101530, and HL 104985.


Story Source:

The above story is based on materials provided by Washington University in St. Louis. The original article was written by Caroline Arbanas. Note: Materials may be edited for content and length.


Journal Reference:

  1. Andrew H. Walton, Jared T. Muenzer, David Rasche, Jonathan S. Boomer, Bryan Sato, Bernard H. Brownstein, Alexandre Pachot, Terrence L. Brooks, Elena Deych, William D. Shannon, Jonathan M. Green, Gregory A. Storch, Richard S. Hotchkiss. Reactivation of Multiple Viruses in Patients with Sepsis. PLoS ONE, 2014; 9 (6): e98819 DOI: 10.1371/journal.pone.0098819

Cite This Page:

Washington University in St. Louis. "Dormant Viruses Re-Emerge in Patients with Lingering Sepsis, Signaling Immune Suppression." ScienceDaily. ScienceDaily, 12 June 2014. <www.sciencedaily.com/releases/2014/06/140612085017.htm>.
Washington University in St. Louis. (2014, June 12). Dormant Viruses Re-Emerge in Patients with Lingering Sepsis, Signaling Immune Suppression. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2014/06/140612085017.htm
Washington University in St. Louis. "Dormant Viruses Re-Emerge in Patients with Lingering Sepsis, Signaling Immune Suppression." ScienceDaily. www.sciencedaily.com/releases/2014/06/140612085017.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins